Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · July 03, 2023

Efficacy of Apraclonidine Eye Drops in Treating Ptosis Secondary to Myasthenia Gravis

Muscle & Nerve


Additional Info

Muscle & Nerve
Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial
Muscle Nerve 2023 May 31;[EPub Ahead of Print], M Agha, H Ismail, R Sawaya, J Salameh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading